摘要
Objective: To investigate the efficacy of Integrative medicine (IM), compare with Western medicine (WM), in the treatment of rheumatoid arthritis (RA) in a cohort study. Methods: This is a cohort study with recruitment of RA patients from 10 hospitals in China. The primary outcome was change in disease activity score 28 (DAS28) during 4 follow-up visits. Generalized estimating equation (GEE) models that controlled for variables were used to investigate a time trend and assess group differences in the primary outcome and secondary outcomes after propensity score matching (PSM). Results: A total of 3195 patients with RA received IM (n = 1379, 43.2%) or WM (n = 1816, 56.8%). Following 1:1 propensity score matching, 1,331 eligible patients prescribed IM were compared to 1,331 matched patients prescribed WM. The GEE analysis with PSM showed that the IM was more beneficial to significantly decrease the levels of VAS, PGA and PhGA (VAS: odds ratio (OR), 0.76; 95% CI, 0.63-0.92; p = 0.004; PGA: OR, 0.76; 95% CI, 0.64-0.92; p = 0.007; and PhGA: OR, 0.77; 95% CI, 0.64, 0.93; p = 0.004), and reduce DAS28 (OR, 0.84; 95% CI, 0.73-0.98; p = 0.030) in the per-protocol population. Conclusion: This study suggests that compare to WM, IM has advantages in improving RA-related outcomes. However, the statistical significance might not reveal significant clinical difference. Further studies should be focused on specific treatment strategies and/or disease stages.
学科与关键词
- Conventional disease-modifying anti-rheumatic drugs combined with Chinese Herbal Medicines for rheumatoid arthritis: A systematic review and meta-analysisHan, Rong; Ren, Hong Cheng; Zhou, Sitong; Gu, Sherman; Gu, Yue-Yu; Sze, Daniel Man-yuen*; Chen, Meng-Hua*JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE, 2022, 12(5): 437-446.被引 8
- Real-world effects of Yishen Tongbi decoction for rheumatoid arthritis: protocol for a prospective, observational, multicenter cohort study with validation against double-blind, randomized, controlled trialLiu, Lijuan; Zhu, Fangfang; Xin, Yijun; Zhang, Lu; Hu, Congqi; Xu, Yanping; Zhang, Jinming; Liu, Lingjie; Chen, Guangxing*Frontiers in Pharmacology, 2024, 15: 1320578.
- Management of rheumatoid arthritis in China: a study of the implementation of 2019 EULAR recommendationsJin, Shangyi; Jiang, Nan; Huo, Yuehong; Duan, Xinwang; Fang, Yongfei; Zhao, Cheng; Li, Hongbin; Yang, Min; Huang, Zhirao; Yang, Pingting; Zhang, Hongfeng; Zhan, Feng; Wang, Youlian; Wang, Yanhong; Wu, Chanyuan; Wang, Qian; Hsieh, Evelyn; Li, Mengtao; Tian, Xinping; Zhao, Yan; Zeng, XiaofengAnnals of the Rheumatic Diseases, 2022, 81(7): 1052-1054.被引 1
